Savara Pharmaceuticals
SVRA
#6474
Rank
HK$4.48 B
Marketcap
HK$26.15
Share price
3.70%
Change (1 day)
-7.59%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -HK$0.59 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$0.43 Billion a decrease over its 2022 earnings that were of -HK$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.59 Billion38.26%
2023 -HK$0.43 Billion43.38%
2022 -HK$0.3 Billion-11.31%
2021 -HK$0.34 Billion-13.3%
2020 -HK$0.39 Billion-36.53%
2019 -HK$0.61 Billion13.76%
2018 -HK$0.54 Billion105.54%
2017 -HK$0.27 Billion34.11%
2016 -HK$0.2 Billion-37.43%
2015 -HK$0.32 Billion38.81%
2014 -HK$0.23 Billion33.62%
2013 -HK$0.17 Billion38.49%
2012 -HK$0.13 Billion24.59%
2011 -HK$96.91 Million-36.5%
2010 -HK$0.16 Billion-3.14%
2009 -HK$0.16 Billion-23.28%
2008 -HK$0.21 Billion8.52%
2007 -HK$0.19 Billion-34.14%
2006 -HK$0.29 Billion184.43%
2005 -HK$0.11 Billion90.75%
2004 -HK$52.97 Million190.35%
2003 -HK$18.25 Million11.64%
2002 -HK$16.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.15 Billion-75.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.91 Billion 224.94%๐Ÿ‡บ๐Ÿ‡ธ USA